Biomerica Inc BMRA Q1 2026 Earnings Negative EPS Persists Amid PreRevenue Stage NewAmsterdam Pharma NAMS Q1 2026 Earnings Narrowerthanexpected loss as biotech advances pipeline MNDO Q1 2025 Earnings Modest Profitability Drives Positive Stock Reaction PTEN Q1 2026 Earnings PattersonUTI Posts NarrowerThanExpected Loss as Cost Controls and Drilling Efficiency Improve SANUWAVE Health Q1 2026 Earnings EPS Misses Estimates by 2838 Revenue Not Disclosed LANDO Q1 2026 Earnings Preferred Stock Stays Steady With Slight EPS Beat